Health and Fitness Health and Fitness
Thu, September 6, 2012
[ Thu, Sep 06th 2012 ] - Market Wire
Durata Therapeutics Completes Target Enrollment i .. Trial Comparing Dalbavancin to Vancomycin and Li
[ Thu, Sep 06th 2012 ] - Market Wire
Apremilast Palace Program Demonstrates Robust and .. nificant Clinical Benefit Across Three Pivotal Ph
[ Thu, Sep 06th 2012 ] - Market Wire
Advaxis Will Present at Rodman & Renshaw Annual Healthcare Conference
[ Thu, Sep 06th 2012 ] - Market Wire
Derma Sciences Launches MEDIHONEY®; HCS in the U.S.
[ Thu, Sep 06th 2012 ] - Market Wire
Mylan Launches First Ever App of Its Generic Brand Reference Guide
[ Thu, Sep 06th 2012 ] - Market Wire
PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
[ Thu, Sep 06th 2012 ] - Market Wire
Dana-Farber Cancer Institute's Ursula A. Matuloni .. NMD-2076 Published in the European Journal of Can
[ Thu, Sep 06th 2012 ] - Market Wire
Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
[ Thu, Sep 06th 2012 ] - Market Wire
Spectrum Pharmaceuticals Completes Acquisition of .. ctive and Swift Integration Expected to Result In
[ Thu, Sep 06th 2012 ] - Market Wire
Teleflex Signs New Innovative Technology Agreemen .. ; VPS®; Vascular Positioning System&re
[ Thu, Sep 06th 2012 ] - Market Wire
Natus to Present at the UBS Global Life Sciences Conference
[ Thu, Sep 06th 2012 ] - Market Wire
Isis Pharmaceuticals Expands Use of BioClinica Express EDC
Wed, September 5, 2012
[ Wed, Sep 05th 2012 ] - Market Wire
Concord Medical Responds to Unusual Market Activity in its Stock
[ Wed, Sep 05th 2012 ] - Market Wire
Hologic Announces Verdict In Patent Infringement Suit
[ Wed, Sep 05th 2012 ] - Market Wire
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
[ Wed, Sep 05th 2012 ] - Market Wire
Abattis Biologix Announces Share Consolidation and Name Change
[ Wed, Sep 05th 2012 ] - Market Wire
Fresenius Medical Care Provides Uninterrupted Car .. for Dialysis Patients Affected by Hurricane Isaac
[ Wed, Sep 05th 2012 ] - Market Wire
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
[ Wed, Sep 05th 2012 ] - Market Wire
NeuroMetrix to Present at Rodman & Renshaw Annual ;Global Investment ;Conference
[ Wed, Sep 05th 2012 ] - Market Wire
Tengion Common Stock to Begin Trading on The OTCQ .. Tier of the OTC Marketplace on September 6, 2012
[ Wed, Sep 05th 2012 ] - Market Wire
Endo Health Solutions to Present at UBS 2012 Global Life Sciences Conference
[ Wed, Sep 05th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Announces 30 Mont .. ety Update for XIAFLEX in Dupuytren's Contracture
[ Wed, Sep 05th 2012 ] - Market Wire
Gilead Sciences to Present at the Morgan Stanley .. Healthcare Conference on Wednesday, September 12
[ Wed, Sep 05th 2012 ] - Market Wire
Navidea Biopharmaceuticals to Present at Upcoming Investor Conferences
[ Wed, Sep 05th 2012 ] - Market Wire
Kindred Healthcare to Participate in the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 05th 2012 ] - Market Wire
Grifols Auszeichnungsgewinner des 9. alljhrlichen .. ALTA Forschungsstipendium bei der 2012 ERS Tagung
[ Wed, Sep 05th 2012 ] - Market Wire
Grifols premia a los ganadores de la 9th Annual eALTA Research Fellowship en la reunin ERS 2012
[ Wed, Sep 05th 2012 ] - Market Wire
Sun Healthcare Group, Inc. Announces Results of S .. s in Connection With Proposed Transaction With Ge
[ Wed, Sep 05th 2012 ] - Market Wire
Herbalife Ltd. to Present at the 2012 Barclays Back-to-School Consumer Conference
[ Wed, Sep 05th 2012 ] - Market Wire
Alexion to Present at Morgan Stanley Global Healthcare Conference

Alexion to Present at Morgan Stanley Global Healthcare Conference


Published on 2012-09-05 08:01:40 - Market Wire
  Print publication without navigation


CHESHIRE, Conn.--([ ])--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Morgan Stanley Global Healthcare Conference in New York City at 9:45 a.m. Eastern time on Wednesday, September 12, 2012.

An audio webcast of Dr. Bellas remarks will be available live. You can access the webcast at: [ www.alexionpharma.com ]. An archived version of the remarks will also be available through the Companyas web site for a limited time following the conference.

[ALXN-G]

Contributing Sources